tris-Azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release

A series of tris-azaaromatic quaternary ammonium salts has been synthesized and evaluated for their ability to inhibit neuronal nicotinic acetylcholine receptors (nAChRs) mediating nicotine-evoked [ 3H]dopamine release from superfused rat striatal slices and for inhibition of [ 3H]nicotine and [ 3H]...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2007-12, Vol.17 (24), p.6701-6706
Hauptverfasser: Zheng, Guangrong, Sumithran, Sangeetha P., Deaciuc, Agripina G., Dwoskin, Linda P., Crooks, Peter A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of tris-azaaromatic quaternary ammonium salts has been synthesized and evaluated for their ability to inhibit neuronal nicotinic acetylcholine receptors (nAChRs) mediating nicotine-evoked [ 3H]dopamine release from superfused rat striatal slices and for inhibition of [ 3H]nicotine and [ 3H]methyllycaconitine binding to whole rat brain membranes. The 3-picolinium compound 1,3,5-tri-{5-[1-(3-picolinium)]-pent-1-ynyl}benzene tribromide (tPy3PiB), 3b, exhibited high potency and selectivity for nAChR subtypes mediating nicotine-evoked [ 3H]dopamine release with an IC 50 of 0.2 nM and I max of 67%. A series of tris-azaaromatic quaternary ammonium salts has been synthesized and evaluated for their ability to inhibit neuronal nicotinic acetylcholine receptors (nAChRs) mediating nicotine-evoked [ 3H]dopamine release from superfused rat striatal slices and for inhibition of [ 3H]nicotine and [ 3H]methyllycaconitine binding to whole rat brain membranes. The 3-picolinium compound 1,3,5-tri-{5-[1-(3-picolinium)]-pent-1-ynyl}benzene tribromide (tPy3PiB), 3b, exhibited high potency and selectivity for nAChR subtypes mediating nicotine-evoked [ 3H]dopamine release with an IC 50 of 0.2 nM and I max of 67%.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2007.10.062